Jimena Pérez-Vargas

7PUBLICATIONS
43CO-AUTHORS
Pharmaceutical delivery technologiesMedical virologyCheminformatics and quantitative structure-activity relationshipsMedical devicesDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
A reversible broad-spectrum antiviral targets the human V-ATPase VO domain.

|Jun 03, 2025
Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance.

Natalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong

|Aug 09, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.

Jimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead

|Jul 02, 2021
HDV-Like Viruses.

Jimena Pérez-Vargas, Rémi Pereira de Oliveira, Stéphanie Jacquet

|May 10, 2019
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo.

Jimena Perez-Vargas, Fouzia Amirache, Bertrand Boson

|Nov 04, 2017
A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion.

P Guardado-Calvo, K Atkovska, S A Jeffers

Pageof 2

Frequent Collaborators

3 joint publications

François-Loïc Cosset

2 joint publications

Masahiro Niikura

2 joint publications

Mark Paetzel

2 joint publications

Jason R Smith